Taivex Therapeutics Corporation
5 clinical trials · Sponsor
◉ Watch Taivex Therapeutics Corporation
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors (NCT05156203) | Taivex Therapeutics Corporation | 2021-12-19 |
| Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors (NCT04866641) | Taivex Therapeutics Corporation | 2021-06-24 |
| Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors (NCT04685473) | Taivex Therapeutics Corporation | 2021-01-07 |
| An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors (NCT03349073) | Taivex Therapeutics Corporation | 2017-09-14 |
| Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors (NCT03195764) | Taivex Therapeutics Corporation | 2017-09-14 |
Track Taivex Therapeutics Corporation automatically
Every clearance here is in the API, with alerts when new ones post.